id
stringlengths
12
14
question
dict
document
dict
evidence
dict
answer
dict
tags
listlengths
0
0
qtjf0226-1180
{ "id": "1180", "text": "when was this last updated ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "qtjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "august 1, 2002", "August 1, 2002" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
qtjf0226-1181
{ "id": "1181", "text": "Who is the lead responsible person for draft justification for actos 508?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "qtjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Amy Hagaman/Alfonso Perez" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
lmjf0226-1195
{ "id": "1195", "text": "Which is the core organization of Takeda pharmaceutical Company?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "lmjf0226", "type": 9, "count_pages": 17, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Pharmaceutical development Division", "Pharmaceutical Development Division" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
lmjf0226-1196
{ "id": "1196", "text": "Who made the opening remarks ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "lmjf0226", "type": 9, "count_pages": 17, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Dr. Kitazawa" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
lmjf0226-1197
{ "id": "1197", "text": "When is the clinical expert meeting scheduled?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "lmjf0226", "type": 9, "count_pages": 17, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "October 1 and 2", "for October 1 and 2." ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
nqjf0226-1198
{ "id": "1198", "text": "what is the date mentioned in the given information ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "nqjf0226", "type": 9, "count_pages": 2, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "20 April 2006", "20 april 2006" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
nqjf0226-1199
{ "id": "1199", "text": "What is the meeting time mentioned here?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "nqjf0226", "type": 9, "count_pages": 2, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "4:00pm - 5:00pm" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
nqjf0226-1200
{ "id": "1200", "text": "what is the place mentioned ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "nqjf0226", "type": 9, "count_pages": 2, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "meeting room 403", "Meeting Room 403" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
lmjf0226-1201
{ "id": "1201", "text": "Why was it suggested to prepare non-clinical \"White paper\"?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "lmjf0226", "type": 9, "count_pages": 17, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "to address the bladder issue", "to address the bladder issue." ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
nqjf0226-1202
{ "id": "1202", "text": "who will forward the article regarding rosiglitazone and non clinical bladder data to andy ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "nqjf0226", "type": 9, "count_pages": 2, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Mondira" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1204
{ "id": "1204", "text": "Who presented an outline of the Cohen hypothesis?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Philip Collett" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1205
{ "id": "1205", "text": "What is significant in the development of calculi?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Raising the pH of male rat urine above 6.5" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1206
{ "id": "1206", "text": "What is the correlation observed in cohen's paper?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "0.61" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1207
{ "id": "1207", "text": "Why didn't rats eliminate calculi as humans do?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Because rats are quadropeds.", "Because rats are quadropeds" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
gmjf0226-1208
{ "id": "1208", "text": "What is the fullform of MAA?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "gmjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Marketing Authorization Application" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jsjf0226-1212
{ "id": "1212", "text": "Who is the Director of Nonclinical Safety and Efficacy?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jsjf0226", "type": 9, "count_pages": 2, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "David Baron", "David baron" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jsjf0226-1213
{ "id": "1213", "text": "Who described tumor promoter-model study?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jsjf0226", "type": 9, "count_pages": 2, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Dr. El-Hage", "dr. el-hage" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jsjf0226-1214
{ "id": "1214", "text": "What is the duration of daily dosing?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jsjf0226", "type": 9, "count_pages": 2, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "32-weeks", "32-weeks after BBN." ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1215
{ "id": "1215", "text": "Who updated the CEO on August 6?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Mr. Saito" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1216
{ "id": "1216", "text": "By when should TPNA send outline of response to TCI ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "by August 19", "August 19" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1217
{ "id": "1217", "text": "When will Mr. Saito present outline to CEO?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "on August 20", "August 20" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
fsjf0226-1219
{ "id": "1219", "text": "When will the FDA Conference Call be held?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "fsjf0226", "type": 9, "count_pages": 2, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "July 31, 2002" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
qtjf0226-1220
{ "id": "1220", "text": "What is the heading of the document?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "qtjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "ACTOS FDA RESPONSE TASK FORCE-TPNA" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
qtjf0226-1221
{ "id": "1221", "text": "How many key issues does the FDA have with respect to the non-clinical data related to bladder tumors?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "qtjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "The FDA has 3 key issues with respect to the non-clinical data related to bladder tumors.", "3" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
qtjf0226-1222
{ "id": "1222", "text": "What plan is developed by TPNA?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "qtjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "monitoring plan", "TPNA will develop monitoring plan." ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
qtjf0226-1223
{ "id": "1223", "text": "What is TPNA's goal?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "qtjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "is to supply justification to support maintaining current labeling." ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
qtjf0226-1225
{ "id": "1225", "text": "What is the last point in the table?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "qtjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 7 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "EVALUATE IMPACT ON TAK-559", "Evaluate Impact on Tak-559" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
qtjf0226-1227
{ "id": "1227", "text": "What is the Draft's Due Date?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "qtjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 7 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "August 5" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ttjf0226-1228
{ "id": "1228", "text": "Which benefit start after 1 year of service?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ttjf0226", "type": 9, "count_pages": 5, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 4 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Extended Disability", "extended disability" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
lmjf0226-1229
{ "id": "1229", "text": "What is Ms Wakamatsu's role in Dept. Strategic Development?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "lmjf0226", "type": 9, "count_pages": 17, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Assistant Manager", "Assistant manager" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
pljf0226-1230
{ "id": "1230", "text": "Which drug's toxicity study results will be discussed ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "pljf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 5 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "pioglitazone" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1233
{ "id": "1233", "text": "Who challenged authorities regrading implementing monitoring plan?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Takeda Europe" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1234
{ "id": "1234", "text": "What content is high in male rat urine?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "protein", "protien content" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1235
{ "id": "1235", "text": "What kind of meeting is mentioned in this letter?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "ACTOS FDA RESPONSE MEETING" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1239
{ "id": "1239", "text": "what kind of drug is used to treat the group of rats?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "pioglitazone", "Pioglitazone" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1240
{ "id": "1240", "text": "In the rat oncogenicity study, what was observed in male rats?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 2 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "thickening of the bladder and hypertrophy of the urothelium" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
qtjf0226-1241
{ "id": "1241", "text": "What is the due date to conduct review meeting for FDA package?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "qtjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 6 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "August 22" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1242
{ "id": "1242", "text": "What is the time span where no tumors are seen?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 2 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "shorter term (12 month)" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
qtjf0226-1243
{ "id": "1243", "text": "Who is the lead responsible person for the compilation of FDA package?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "qtjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 6 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Larry Hancock" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1244
{ "id": "1244", "text": "According to mouse oncogenicity study, what was seen male mice only?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 2 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "hyperplasia" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1245
{ "id": "1245", "text": "what kind of cell tumours experienced the same frequency when group of rats treated with pioglitazone?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "transitional", "transitional cell tumors" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
myjf0226-1246
{ "id": "1246", "text": "who conducted robust program?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "myjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 2 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "TCI" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
qtjf0226-1247
{ "id": "1247", "text": "What is the task assigned to David Baron?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "qtjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 6 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Send nonclinical rationale/justification section to medical writing for compilation", "Send nonclinical rationale/justification section to medical writing for compilation." ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
qtjf0226-1248
{ "id": "1248", "text": "Who is responsible for sending package to TCI/EU for review?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "qtjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 6 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Mary Ramstack" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
hrjf0226-1253
{ "id": "1253", "text": "Which product's liability claims are described here?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "hrjf0226", "type": 9, "count_pages": 3, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "ACTOS PRODUCTS LIABILITY CLAIMS", "ACTOS PRODUCTS" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ltjf0226-1255
{ "id": "1255", "text": "Mention the first name listed in the \"apologies\"?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ltjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Professor Ele Ferrannini" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
hrjf0226-1256
{ "id": "1256", "text": "What is the exhibit number?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "hrjf0226", "type": 9, "count_pages": 3, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "52" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ltjf0226-1259
{ "id": "1259", "text": "when was the last meeting/conference call held on ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ltjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "15th October 2005", "15 October 2005" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jsjf0226-1260
{ "id": "1260", "text": "What is the exhibit number?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jsjf0226", "type": 9, "count_pages": 2, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "107" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ltjf0226-1262
{ "id": "1262", "text": "what is the date mentioned under the title - \" minutes of conference call\"?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ltjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "28th November 2005", "Monday 28th November 2005", "monday 28th november 2005" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jpjf0226-1265
{ "id": "1265", "text": "what is the title of chapter 3?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jpjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 2 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "document storage period", "Document Storage Period" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
xqjf0226-1266
{ "id": "1266", "text": "What is the graphical representation about?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "xqjf0226", "type": 9, "count_pages": 10, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Summary of Segment Attractiveness" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
xqjf0226-1267
{ "id": "1267", "text": "On what basis, the Summary of Segment Attractiveness is carried out?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "xqjf0226", "type": 9, "count_pages": 10, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "based on current situation & future trends", "Based on current situation & future trends.", "current situation & future trends" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
xqjf0226-1268
{ "id": "1268", "text": "What are the three segments indicated in the graph?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "xqjf0226", "type": 9, "count_pages": 10, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Treatment Machines, Life Negotiators, Struggle for Control" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
xqjf0226-1270
{ "id": "1270", "text": "What is the conclusion obtained from the graph?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "xqjf0226", "type": 9, "count_pages": 10, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "All 3 Segments Have Consistent Needs.", "All 3 segments have consistent needs" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jpjf0226-1272
{ "id": "1272", "text": "what is article 4?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jpjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "PRINCIPLES OF CREATING DOCUMENTS", "principles of creating documents", "(PRINCIPLES OF CREATING DOCUMENTS)" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
trjf0226-1273
{ "id": "1273", "text": "Semi exclusive rights in how many countries?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "trjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "20", "20 countries" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jpjf0226-1274
{ "id": "1274", "text": "what is the title of chapter 2?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jpjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "document storage functions", "DOCUMENT STORAGE FUNCTIONS" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
trjf0226-1276
{ "id": "1276", "text": "What percent is the Supply Price / Royalty Rate?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "trjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "30% supply price", "30% SUPPLY PRICE" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jpjf0226-1278
{ "id": "1278", "text": "what is article 6?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jpjf0226", "type": 9, "count_pages": 8, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "duties of responsible person in charge of storage and person in charge of storage", "DUTIES OF RESPONSIBLE PERSON IN CHARGE OF STORAGE AND PERSON IN CHARGE OF STORAGE", "(DUTIES OF RESPONSIBLE PERSON IN CHARGE OF STORAGE AND PERSON IN CHARGE OF STORAGE)" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
trjf0226-1279
{ "id": "1279", "text": "In how many countires, license to Exclusive rights are provided?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "trjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "60 COUNTRIES", "in approximately 60 countries", "60" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jfkf0226-1280
{ "id": "1280", "text": "what is the name of pediatric program?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jfkf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "ACTOS", "ACTOS PEDIATRIC PROGRAM" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jfkf0226-1282
{ "id": "1282", "text": "What is the date mentioned in this page?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jfkf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "5 October 2006" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1294
{ "id": "1294", "text": "What is the title of this page?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 16 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Actos plan overview", "ACTOS PLAN OVERVIEW" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1295
{ "id": "1295", "text": "which are prescibed eariler in the treatment of type 2 diabetes under the title of \"critical success factors\"?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 16 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "TZD's", "TZD'S" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1301
{ "id": "1301", "text": "What is the Plan TZD Share for the year 2003?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 2 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "19.7%" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1303
{ "id": "1303", "text": "Which year has 13.3% Oral share (TZD)?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 2 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "2000" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1304
{ "id": "1304", "text": "which has a superior lipid profile(v. avandia and others) under the title of \"strength/opportunities?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 16 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "ACTOS" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jfkf0226-1309
{ "id": "1309", "text": "Which study's synopsis is this?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jfkf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "clinical", "Clinical Study" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jfkf0226-1310
{ "id": "1310", "text": "what is the code mentioned under the title of clinical study synopsis?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jfkf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "01-06-TL-OPI-527" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jfkf0226-1311
{ "id": "1311", "text": "When was expert advisory meeting ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jfkf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "4 october 2006", "4 OCTOBER 2006" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jfkf0226-1313
{ "id": "1313", "text": "What is the full form of PPSR?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jfkf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 2 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Proposed Pediatric Study Request", "PROPOSED PEDIATRIC STUDY REQUEST" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
hfkf0226-1316
{ "id": "1316", "text": "What study is described in the table given?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "hfkf0226", "type": 9, "count_pages": 20, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 6 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "PLACEBO- CONTROLLED DOSE RANGING STUDY", "Glycemic Parameters in a 26-Week Placebo-Controlled Dose-Ranging Study." ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
hfkf0226-1317
{ "id": "1317", "text": "Which parameters are considered for the study(see heading of table 2)?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "hfkf0226", "type": 9, "count_pages": 20, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 6 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "GLYCEMIC", "Glycemic Parameters" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
hfkf0226-1318
{ "id": "1318", "text": "Prior to what, the patients entered an 8 week washout/run-in-period?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "hfkf0226", "type": 9, "count_pages": 20, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 6 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "double-blind treatment" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
trjf0226-1320
{ "id": "1320", "text": "What is the floor supply price?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "trjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 4 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "$0.17 / 30 mg or Takeda's cost from site of lowest cost" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
trjf0226-1321
{ "id": "1321", "text": "What is the royalty adjustment if generic enters the market ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "trjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 4 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "50% royalty adjustment", "50%" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
trjf0226-1322
{ "id": "1322", "text": "what is the promotional trails data usage for( Lilly in exclusive) ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "trjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 4 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Split of 70/30", "split of 70/30 (Lilly in exclusive)", "Split of 70/30 (Lilly in Exclusive)" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
trjf0226-1324
{ "id": "1324", "text": "What is the promotional trials data usage for (semi exclusive)?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "trjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 4 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "50/50 in Semi-exclusive" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1325
{ "id": "1325", "text": "what is the name of the plan review ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Marketing plan review.", "MARKETING PLAN REVIEW", "MARKETING PLAN" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
yljf0226-1328
{ "id": "1328", "text": "What is the goal of TPNA?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "yljf0226", "type": 9, "count_pages": 3, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "to supply justification to support maintaining current labeling." ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
trjf0226-1329
{ "id": "1329", "text": "what is the first point given in table for bladder cancer alongside of clinical findings ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "trjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "observed during preclinical studies in rats", "OBSERVED DURING PRECLINICAL STUDIES IN RATS" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1331
{ "id": "1331", "text": "Mention the year given for Actos?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 0 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Actos 2004", "2004" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1333
{ "id": "1333", "text": "what is the percentage of TZD share in the year 2000 ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "40.3%" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1335
{ "id": "1335", "text": "what is Actos TRx (000s) in the year 2003 ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "9,497" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
trjf0226-1337
{ "id": "1337", "text": "how much percent of drug quantity present in rezulin under the title of 'clinical findings'?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "trjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "1.7%", "1.7" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1339
{ "id": "1339", "text": "what is the percentage of plan TZD share in the year 2004 ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "42.9%" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
trjf0226-1340
{ "id": "1340", "text": "how much percent of placebo present in avandia alongside of the clinical findings?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "trjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "0.20", "0.20%" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1341
{ "id": "1341", "text": "in which month and the year the launch of Merck's PPAR's took place?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "FEB 2005", "feb 2005" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1342
{ "id": "1342", "text": "what is the TZD's TRx (000s) in the year 2005 ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "22,902" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
trjf0226-1343
{ "id": "1343", "text": "what is the total number of all claims under the title of \"summary of litigation risk in the ous territories\"?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "trjf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 3 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "10" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1344
{ "id": "1344", "text": "what is the first TZD used for type 2 patients ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 12 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "ACTOS", "Actos" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1345
{ "id": "1345", "text": "For which type of diabetes the TZD's prescribed earlier in treatment?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 12 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Type 2 diabetes" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
ynjf0226-1346
{ "id": "1346", "text": "what has to be establish as the the best OAD medication by treating insulin resistance ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "ynjf0226", "type": 9, "count_pages": 18, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 12 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "ACTOS", "Actos" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
gmjf0226-1347
{ "id": "1347", "text": "What is the Specific example given?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "gmjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "Pioglitazone: Need to commit to studies to investigate certain signals", "pioglitazone: need to commit to studies to investigate certain signals" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jfkf0226-1348
{ "id": "1348", "text": "what is the month and year of overview of submission ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jfkf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "NOVEMBER 2006", "November 2006" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
gmjf0226-1349
{ "id": "1349", "text": "Which country would have similar interest as in Europe?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "gmjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "USA", "usa" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
gmjf0226-1351
{ "id": "1351", "text": "What is the Suggestion from Glyn?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "gmjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "TGRD would formulate direct Risk Management plan and obtain Japan's input", "tgrd would formulate direct risk management plan and obtain japan's input" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
jfkf0226-1352
{ "id": "1352", "text": "what is the executive summary of bladder cancer cases ?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "jfkf0226", "type": 9, "count_pages": 6, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "CONFIRM" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]
gmjf0226-1353
{ "id": "1353", "text": "Full form of PEM?", "type": 7, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide question type." } ] }
{ "id": "gmjf0226", "type": 9, "count_pages": 4, "tags": [ { "name": 0, "target": "type", "comment": "MPDocVQA does not provide document type." } ] }
{ "pages": [ 1 ], "sources": [ 6 ], "tags": [ { "name": 0, "target": "sources", "comment": "MPDocVQA does not provide evidence sources." } ] }
{ "type": 0, "variants": [ "prescription event monitoring" ], "rationale": "", "format": 8, "tags": [ { "name": 2, "target": "type", "comment": "MPDocVQA only contains answerable questions." }, { "name": 0, "target": "format", "comment": "MPDocVQA does not provide answer format." }, { "name": 0, "target": "rationale", "comment": "MPDocVQA does not provide rationale for answers." } ] }
[]